SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-200540
Filing Date
2023-08-01
Accepted
2023-08-01 16:06:39
Documents
53
Period of Report
2023-07-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d470879d8k.htm   iXBRL 8-K 42163
2 EX-4.1 d470879dex41.htm EX-4.1 72324
3 EX-4.2 d470879dex42.htm EX-4.2 18904
4 EX-10.1 d470879dex101.htm EX-10.1 259429
5 EX-10.2 d470879dex102.htm EX-10.2 94736
6 EX-99.1 d470879dex991.htm EX-99.1 11338
7 EX-99.2 d470879dex992.htm EX-99.2 28513
11 GRAPHIC g470879ex99_2p10g1.jpg GRAPHIC 235477
12 GRAPHIC g470879ex99_2p11g1.jpg GRAPHIC 228033
13 GRAPHIC g470879ex99_2p12g1.jpg GRAPHIC 86252
14 GRAPHIC g470879ex99_2p13g1.jpg GRAPHIC 278229
15 GRAPHIC g470879ex99_2p14g1.jpg GRAPHIC 332767
16 GRAPHIC g470879ex99_2p15g1.jpg GRAPHIC 201056
17 GRAPHIC g470879ex99_2p16g1.jpg GRAPHIC 420079
18 GRAPHIC g470879ex99_2p17g1.jpg GRAPHIC 61413
19 GRAPHIC g470879ex99_2p18g1.jpg GRAPHIC 162161
20 GRAPHIC g470879ex99_2p19g1.jpg GRAPHIC 168072
21 GRAPHIC g470879ex99_2p1g1.jpg GRAPHIC 113161
22 GRAPHIC g470879ex99_2p20g1.jpg GRAPHIC 196058
23 GRAPHIC g470879ex99_2p21g1.jpg GRAPHIC 191720
24 GRAPHIC g470879ex99_2p22g1.jpg GRAPHIC 205433
25 GRAPHIC g470879ex99_2p23g1.jpg GRAPHIC 196571
26 GRAPHIC g470879ex99_2p24g1.jpg GRAPHIC 284290
27 GRAPHIC g470879ex99_2p25g1.jpg GRAPHIC 72223
28 GRAPHIC g470879ex99_2p26g1.jpg GRAPHIC 122288
29 GRAPHIC g470879ex99_2p27g1.jpg GRAPHIC 176060
30 GRAPHIC g470879ex99_2p28g1.jpg GRAPHIC 225876
31 GRAPHIC g470879ex99_2p29g1.jpg GRAPHIC 221732
32 GRAPHIC g470879ex99_2p2g1.jpg GRAPHIC 555493
33 GRAPHIC g470879ex99_2p30g1.jpg GRAPHIC 115411
34 GRAPHIC g470879ex99_2p31g1.jpg GRAPHIC 170977
35 GRAPHIC g470879ex99_2p32g1.jpg GRAPHIC 134637
36 GRAPHIC g470879ex99_2p33g1.jpg GRAPHIC 320287
37 GRAPHIC g470879ex99_2p34g1.jpg GRAPHIC 226165
38 GRAPHIC g470879ex99_2p3g1.jpg GRAPHIC 279809
39 GRAPHIC g470879ex99_2p4g1.jpg GRAPHIC 58449
40 GRAPHIC g470879ex99_2p5g1.jpg GRAPHIC 225445
41 GRAPHIC g470879ex99_2p6g1.jpg GRAPHIC 68544
42 GRAPHIC g470879ex99_2p7g1.jpg GRAPHIC 267831
43 GRAPHIC g470879ex99_2p8g1.jpg GRAPHIC 220011
44 GRAPHIC g470879ex99_2p9g1.jpg GRAPHIC 236942
45 GRAPHIC g470879g0729092545854.jpg GRAPHIC 5379
  Complete submission text file 0001193125-23-200540.txt   10513927

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA fbrx-20230728.xsd EX-101.SCH 2859
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbrx-20230728_lab.xml EX-101.LAB 17994
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbrx-20230728_pre.xml EX-101.PRE 11267
47 EXTRACTED XBRL INSTANCE DOCUMENT d470879d8k_htm.xml XML 3343
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Filer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38052 | Film No.: 231131700
SIC: 2834 Pharmaceutical Preparations